We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.
HFA and NHF have responded to our community’s needs and assembled a Safety Summit to be held in January of 2020.
The therapy is for patients with severe and moderately severe hemophilia B.
These activities are the product of a collaboration between Medscape, NHF, the European Haemophilia Consortium and the World Federation of Hemophilia.
This new study will investigate if new therapies have resulted in better outcomes related to brain function in young hemophilia patients.
Subscribe to Our Newsletter
Fill in the fields below to receive our email newsletter.